Loading
Latest filing published 27 Apr 2026 for 휴메딕스.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
휴온스글로벌 discloses dealings in 4 companies, chiefly 휴엠앤씨, 휴메딕스 and 휴온스. Over a trading history stretching from 8 April 2021 to 23 April 2026, the count stands at 24 filings.
In open-market terms, that means 21 purchases worth €196k on one side and 2 sales on the other. The totals do not cover 21 filings with an undisclosed amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2026 to date brings 6 purchases and 1 sale.
The 20 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 27 April 2026 came the latest disclosure, an open-market purchase in 휴메딕스. Filings reach the DART (FSS) feed a median of 7 days after the trade. That lag is the time during which only the insider knows about the trade. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24 of 24 declarations